Keren Landman, Jason McLellan, and Barney Graham discuss the challenges of developing a vaccine for RSV, the impact of RSV on vulnerable populations, and the historical failures of RSV vaccines. They also explain the importance of the F protein, the process of developing a structure-based vaccine for RSV, and the successful testing of the vaccine in mice.